HHS Harte Hanks, Inc. - Common Stock

NASDAQ · Media · View on SEC EDGAR ↗

$2.60

Price · May 19, 2026

Fundamentals as of May 15, 2026

HHS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price

$2.60

Market Cap

$22M

P/E (TTM)

-27.4

EPS (TTM)

$-0.11

Revenue (TTM)

$160M

Div Yield

—

ROE

-3.8%

Debt/Equity

—

52W Range

$2 – $5

HHS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $160M

2016-12-31 → 2025-12-31

EPS $-0.11

2016-12-31 → 2025-12-31

Free Cash Flow $-4M

2016-12-31 → 2025-12-31

Margins -0.51%

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric

5Y trend

HHS

Peer Median

P/E (TTM)

-27.4

14.8

P/S (TTM)

0.1

0.3

P/B

1.1

2.1

Price / FCF

-5.0

—

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric

5Y trend

HHS

Peer Median

Operating Margin

0.24%

—

Net Profit Margin

-0.51%

-3.3%

ROA

-0.84%

-5.6%

ROE

-3.8%

-16.7%

ROIC

1.5%

—

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric

5Y trend

HHS

Peer Median

Current Ratio

1.5

1.1

Quick Ratio

1.1

—

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric

5Y trend

HHS

Peer Median

Revenue YoY

-13.9%

—

Revenue CAGR 3Y

-8.2%

—

Revenue CAGR 5Y

-2.0%

—

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric

5Y trend

HHS

Peer Median

EPS (Diluted)

$-0.11

—

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric

5Y trend

HHS

Peer Median

Dividends Yield, payout ratio, dividend history, 5Y CAGR

Dividend Yield

—

Payout Ratio

—

5Y Div CAGR

—

Ex-date	Amount
Feb. 26, 2016	$0.8500
Nov. 27, 2015	$0.8500
Aug. 28, 2015	$0.8500
May 28, 2015	$0.8500
Feb. 26, 2015	$0.8500
Nov. 26, 2014	$0.8500
Aug. 28, 2014	$0.8500
May 29, 2014	$0.8500
Feb. 27, 2014	$0.8500
Nov. 26, 2013	$0.8500
Aug. 28, 2013	$0.8500
May 30, 2013	$0.8500
Dec. 13, 2012	$0.8500
Nov. 28, 2012	$0.8500
Aug. 29, 2012	$0.8500
May 31, 2012	$0.8500
Feb. 29, 2012	$0.8500
Nov. 30, 2011	$0.8000
Sept. 9, 2011	$0.8000
May 18, 2011	$0.8000

HHS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 5 analysts

Strong Buy 1 20.0%
Buy 3 60.0%
Hold 1 20.0%
Sell 0 0.0%
Strong Sell 0 0.0%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise

0.43%

Period	EPS Actual	EPS Est	Surprise
June 30, 2025	$-0.05	—	—
Sept. 30, 2024	$0.02	$0.10	-0.08%
June 30, 2024	$1.41	$0.05	1.4%
March 31, 2024	$-0.02	$-0.04	0.02%

Peer Comparison Key metrics vs sector peers

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
HHS	$22M	-27.4	-13.9%	-0.51%	-3.8%	—
CDLX	$63M	-0.6	-16.2%	-44.4%	-396.5%	—
CREX	$27M	-4.4	12.5%	-14.5%	-32.5%	44.9%
SWAG	—	—	—	—	—	—
YHC	$19M	-0.3	-37.5%	-1631.0%	-122.9%	10.8%
TULP	$9M	-1.5	—	-15.2%	-45.3%	17.2%
SGRP	$19M	-0.8	-16.8%	-18.1%	-197.6%	15.9%
OMC	$25.28B	-299.1	10.1%	-0.32%	-0.67%	—

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 13

Annual Income Statement data for HHS
Metric	2025	2024	2023	2022	2021	2020	2019	2019	2018	2017	2016	2015
Revenue	$160M	$185M	$191M	$206M	$195M	$177M	$218M	·	$285M	$384M	$404M	$444M
SG&A Expense	$22M	$23M	$21M	$22M	$18M	$22M	$24M	·	·	·	·	·
Operating Expenses	$72M	$79M	$80M	$188M	$178M	$174M	$222M	·	$311M	$425M	$458M	$642M
Operating Income	$386.0K	$2M	$3M	$15M	$8M	$-11M	$-22M	·	$-26M	$-41M	$-54M	$-198M
Other Non-op	$-1M	$-2M	$-5M	$5M	$-477.0K	$-7M	$-7M	·	$-4M	$-6M	$-12M	$-6M
Pretax Income	$-1M	$-38M	$-2M	$19M	$16M	$-18M	$-25M	·	$-562.0K	$-52M	$-69M	$-218M
Income Tax	$-197.0K	$-8M	$-349.0K	$-17M	$1M	$-17M	$2M	·	$-18M	$-10M	$21M	$-37M
Net Income	$-811.0K	$-30M	$-2M	$37M	$15M	$-2M	$-26M	·	$18M	$-42M	·	·
EPS (Basic)	$-0.11	$-4.15	$-0.21	$4.98	$1.85	$-0.34	$-4.26	·	$2.39	$-6.76	$-21.29	$-27.73
EPS (Diluted)	$-0.11	$-4.15	$-0.21	$4.75	$1.76	$-0.34	$-4.26	·	$2.38	$-6.76	$-21.29	$-27.73
Shares (Basic)	7,393,000	7,293,000	7,310,000	7,101,000	6,802,000	6,469,000	6,284,000	·	6,237,000	6,192,000	6,149,000	6,164,000
Shares (Diluted)	7,393,000	7,293,000	7,310,000	7,457,000	7,209,000	6,469,000	6,284,000	·	6,270,000	6,192,000	6,149,000	6,164,000
EBITDA	$5M	$6M	$8M	$18M	$10M	·	$-16M	·	$-19M	·	$-43M	$-173M

Balance Sheet 29

Annual Balance Sheet data for HHS
Metric	2025	2024	2023	2022	2021	2020	2019	2019	2018	2017	2016	2015
Cash & Equivalents	$6M	$10M	$18M	$10M	$12M	$29M	$28M	·	$21M	$8M	$46M	$17M
Receivables	$28M	$32M	$34M	$40M	$41M	$36M	$39M	·	$54M	$81M	$89M	$104M
Inventory	·	·	·	·	·	$46.0K	$354.0K	·	$448.0K	$587.0K	$838.0K	$963.0K
Prepaid Expense	$2M	$2M	$2M	$2M	$2M	$2M	$3M	·	$4M	$5M	$6M	$8M
Other Current Assets	$2M	$1M	$928.0K	$2M	$1M	$886.0K	$2M	·	$3M	$4M	$5M	$7M
Current Assets	$46M	$54M	$65M	$66M	$75M	$86M	$79M	·	$105M	$103M	$149M	$307M
PP&E (Net)	$8M	$9M	$9M	$11M	$8M	$6M	$8M	·	$14M	$22M	$24M	$28M
PP&E (Gross)	$43M	$47M	$45M	$55M	$60M	$76M	$133M	·	$147M	$159M	$165M	$173M
Accum. Depreciation	$35M	$38M	$37M	$44M	$53M	$70M	$125M	·	$134M	$137M	$141M	$145M
Goodwill	$295.0K	$295.0K	$2M	$2M	$0	·	·	·	$0	$0	$35M	$70M
Intangibles	$370.0K	$563.0K	$3M	$4M	$0	·	·	·	$0	$3M	$3M	$4M
Other Non-current Assets	$564.0K	$717.0K	$1M	$2M	$3M	$3M	$4M	·	$7M	$3M	$2M	$2M
Total Assets	$92M	$102M	$123M	$120M	$108M	$119M	$110M	·	$125M	$131M	$213M	$414M
Accounts Payable	$13M	$13M	$23M	$22M	$16M	$16M	$17M	·	$31M	$36M	$46M	$37M
Accrued Liabilities	$6M	$8M	·	·	·	·	·	·	·	·	·	·
Current Liabilities	$30M	$35M	$48M	$44M	$42M	$47M	$46M	·	$54M	$67M	$105M	$98M
Capital Leases	$18M	$20M	$24M	$17M	·	·	$13M	·	·	·	·	$204.0K
Deferred Tax	·	·	·	·	·	·	$244.0K	·	$0	$773.0K	$11M	$21M
Other Non-current Liabilities	$1M	$2M	$2M	$3M	$4M	$5M	$3M	·	$4M	$4M	$5M	$5M
Total Liabilities	$71M	$80M	$103M	$101M	$123M	$163M	$150M	·	$135M	$165M	$211M	$274M
Long-term Debt	·	·	·	·	$5M	$27M	$19M	·	·	$0	$0	$77M
Total Debt	·	·	·	$0	$5M	·	$19M	·	$14M	·	$0	$77M
Common Stock	$12M	$12M	$12M	$12M	$12M	$12M	$12M	·	$12M	$12M	$12M	$120M
Retained Earnings	$814M	$815M	$845M	$846M	$811M	$796M	$798M	·	$813M	$795M	$837M	$974M
Treasury Stock	$900M	$916M	$951M	$1.01B	$1.09B	$1.18B	$1.24B	·	$1.25B	$1.25B	$1.26B	$1.26B
AOCI	$-15M	$-14M	$-44M	$-48M	$-53M	$-66M	$-63M	·	$-46M	$-44M	$-46M	$-44M
Stockholders' Equity	$21M	$22M	$20M	$19M	$-25M	$-53M	$-50M	·	$-19M	$-35M	$3M	$140M
Liabilities + Equity	$92M	$102M	$123M	$120M	$108M	$119M	$110M	·	$125M	$131M	$213M	$414M
Shares Outstanding	7,414,794	7,357,450	7,224,718	7,402,614	6,976,144	6,599,309	6,302,936	·	6,260,075	·	·	·

Cash Flow 17

Annual Cash Flow data for HHS
Metric	2025	2024	2023	2022	2021	2020	2019	2019	2018	2017	2016	2015
D&A	$4M	$4M	$4M	$3M	$3M	$4M	$5M	·	$7M	$11M	$12M	$12M
Stock-based Comp	$258.0K	$2M	$1M	$2M	$1M	$764.0K	$1M	·	$-581.0K	$3M	$3M	$5M
Deferred Tax	$-928.0K	$-9M	$-1M	$-20M	$0	$-244.0K	$996.0K	·	$-2M	$-11M	$26M	$-42M
Amort. of Intangibles	·	·	·	·	·	·	$0	·	$113.0K	$713.0K	$821.0K	$659.0K
Restructuring	$2M	$2M	$6M	$0	$6M	$9M	$12M	·	·	·	·	·
Other Non-cash	$-5M	$30M	$8M	$7M	$-21M	·	$31M	·	$-32M	·	·	·
Operating Cash Flow	$-2M	$-3M	$10M	$29M	$-2M	$-8M	$12M	·	$-9M	$-31M	$15M	$33M
CapEx	$3M	$4M	$3M	$6M	$3M	$3M	$3M	·	$4M	$6M	$7M	$8M
Investing Cash Flow	$-3M	$-4M	$-2M	$-11M	$-3M	$-775.0K	$-3M	·	$-52.0K	$-6M	$100M	$-36M
Stock Issued	·	·	·	·	·	·	·	·	·	$-111.0K	$-233.0K	$-909.0K
Stock Repurchased	·	$0	$2M	$0	·	·	·	·	·	$0	$0	$5M
Net Stock Activity	·	$0	$-2M	·	·	·	·	·	·	·	$-233.0K	$-6M
Dividends Paid	·	·	·	·	·	·	·	·	·	$0	$5M	$21M
Financing Cash Flow	$514.0K	$-419.0K	$-3M	$-16M	$-13M	$7M	$3M	·	$23M	$-1M	$-85M	$-32M
Net Change in Cash	$-4M	$-9M	$8M	$-4M	$-18M	$-560.0K	$13M	·	$12M	$-38M	$29M	$-37M
Taxes Paid	$2M	$1M	$3M	·	$1M	$9M	$19M	·	$-119.0K	$33M	$3M	$10M
Free Cash Flow	$-4M	$-7M	$8M	$23M	$-5M	·	$9M	·	$-13M	·	$8M	$19M

Profitability 7

Annual Profitability data for HHS
Metric	2025	2024	2023	2022	2021	2020	2019	2019	2018	2017	2016	2015
Operating Margin	0.24%	1.1%	1.8%	7.3%	3.9%	·	-9.9%	·	-9.2%	·	-13.8%	-37.9%
Net Margin	-0.51%	-16.4%	-0.82%	17.8%	7.7%	·	-12.1%	·	6.2%	·	·	·
Pretax Margin	-0.63%	-20.5%	-1.0%	9.4%	8.4%	·	-11.3%	·	-0.20%	·	-17.1%	-40.9%
EBITDA Margin	3.0%	3.5%	4.0%	8.6%	5.2%	·	-7.5%	·	-6.5%	·	-10.7%	-35.0%
ROA	-0.84%	-27.0%	-1.3%	32.3%	13.2%	·	-22.3%	·	13.7%	·	·	·
ROE	-3.8%	-141.8%	-7.8%	1222.0%	-47.4%	·	58.3%	·	-93.3%	·	·	·
ROIC	1.5%	7.7%	13.8%	153.0%	-35.7%	·	74.7%	·	-16311.9%	·	-2726.7%	-72.6%

Liquidity & Solvency 4

Annual Liquidity & Solvency data for HHS
Metric	2025	2024	2023	2022	2021	2020	2019	2019	2018	2017	2016	2015
Current Ratio	1.5	1.5	1.4	1.5	1.8	·	1.7	·	1.9	·	1.4	1.6
Quick Ratio	1.1	1.2	1.1	1.1	1.2	·	1.5	·	1.4	·	1.3	1.4
Debt / Equity	·	·	·	0.0	-0.2	·	-0.4	·	-0.7	·	0.0	0.6
LT Debt / Equity	·	·	·	0.0	-0.2	·	-0.4	·	-0.7	·	0.0	0.5

Efficiency 2

Annual Efficiency data for HHS
Metric	Trend	2025	2024	2023	2022	2021	2020	2019	2019	2018	2017	2016	2015
Asset Turnover		1.6	1.6	1.6	1.8	1.7	·	1.8	·	2.2	·	1.3	0.9
Receivables Turnover		5.4	5.6	5.2	5.1	5.0	·	4.7	·	4.3	·	4.2	4.1

Per Share 7

Annual Per Share data for HHS
Metric	2025	2024	2023	2022	2021	2020	2019	2019	2018	2017	2016	2015
Book Value / Share	$2.77	$2.95	$2.75	$2.54	$-3.54	·	$-7.88	·	·	·	·	·
Revenue / Share	$21.58	$25.40	$26.20	$27.66	$26.99	·	$34.62	·	$45.40	·	$6.58	$8.04
Cash Flow / Share	$-0.23	$-0.41	$1.43	$3.86	$-0.24	·	$1.93	·	$-1.46	·	$0.24	$0.50
Cash / Share	$0.75	$1.35	$2.54	$1.40	$1.71	·	$4.46	·	·	·	·	·
Dividend / Share	·	·	·	·	·	·	·	·	·	$0	$1	$3
Dividend Paid / Share	·	·	·	·	·	·	·	·	$0	$0	$1	$3
EPS (TTM)	$-0.11	$-4.15	$-0.21	$4.75	$1.76	$-0.34	$-4.26	$-4.69	$2.38	$-6.76	$-21.29	$-27.73

Growth Rates 5

Annual Growth Rates data for HHS
Metric	2025	2024	2023	2022	2021	2020	2019	2019	2018	2017	2016	2015
Revenue YoY	-13.9%	-3.3%	-7.2%	6.0%	10.0%	·	·	·	·	·	·	·
Revenue CAGR 3Y	-8.2%	-1.6%	2.7%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	-2.0%	·	·	·	·	·	·	·	·	·	·	·
EPS YoY	·	·	·	169.9%	·	·	·	·	·	·	·	·
Net Income YoY	·	·	·	145.6%	·	·	·	·	·	·	·	·

Valuation (TTM) 15

Annual Valuation (TTM) data for HHS
Metric	2025	2024	2023	2022	2021	2020	2019	2019	2018	2017	2016	2015
Revenue TTM	$160M	$185M	$191M	$206M	$195M	$177M	$218M	$263M	$285M	$384M	$404M	$444M
Net Income TTM	$-811.0K	$-30M	$-2M	$37M	$15M	$-2M	$-26M	$-29M	$18M	$-42M	$-81M	$-81M
Market Cap	$22M	$38M	$49M	$87M	$53M	·	$23M	·	·	·	·	·
Enterprise Value	·	·	·	$76M	$46M	·	$13M	·	·	·	·	·
P/E	-27.4	-1.2	-32.3	2.5	4.3	-8.1	-0.8	-0.8	1.0	-1.4	-0.7	-1.2
P/S	0.1	0.2	0.3	0.4	0.3	·	0.1	·	·	·	·	·
P/B	1.1	1.7	2.5	4.6	-2.1	·	-0.5	·	·	·	·	·
P / Tangible Book	1.1	1.8	3.2	6.7	·	·	·	·	·	·	·	·
P / Cash Flow	-12.9	-12.7	4.7	3.0	-30.1	·	1.9	·	·	·	·	·
P / FCF	-5.0	-5.6	6.4	3.8	-11.0	·	2.5	·	·	·	·	·
EV / EBITDA	·	·	·	4.3	4.5	·	-0.8	·	·	·	·	·
EV / FCF	·	·	·	3.3	-9.6	·	1.4	·	·	·	·	·
EV / Revenue	·	·	·	0.4	0.2	·	0.1	·	·	·	·	·
Earnings Yield	-3.6%	-80.6%	-3.1%	40.6%	23.2%	-12.4%	-119.0%	-131.0%	98.4%	-71.2%	-141.0%	-85.6%
Annual Payout	·	·	·	·	·	·	·	·	·	$0	$5M	$21M

Income Statement 13

Quarterly Income Statement data for HHS
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$37M	$40M	$40M	$39M	$42M	$47M	$48M	$45M	$45M	$49M	$47M	$48M	$47M	$55M	$54M	$49M
SG&A Expense	$6M	$6M	$5M	$6M	$6M	$6M	$5M	$6M	$6M	$5M	$5M	$5M	$6M	$5M	$6M	$5M
Operating Expenses	$17M	$17M	$17M	$18M	$20M	$21M	$20M	$20M	$20M	$-53M	$43M	$45M	$45M	$50M	$50M	$44M
Operating Income	$-768.0K	$-117.0K	$509.0K	$34.0K	$-40.0K	$-2M	$2M	$1M	$375.0K	$-2M	$3M	$2M	$1M	$3M	$4M	$4M
Other Non-op	$-161.0K	$-140.0K	$-106.0K	$-386.0K	$-514.0K	$-943.0K	$-831.0K	$45.0K	$-606.0K	$-2M	$-383.0K	$-791.0K	$-3M	$-1M	$5M	$1M
Pretax Income	$-998.0K	$-307.0K	$319.0K	$-413.0K	$-607.0K	$-2M	$1M	$-37M	$-242.0K	$-4M	$3M	$820.0K	$-1M	$2M	$8M	$5M
Income Tax	$-370.0K	$-3M	$3M	$-78.0K	$-215.0K	$570.0K	$868.0K	$-9M	$-71.0K	$-2M	$2M	$240.0K	$-532.0K	$-20M	$1M	$671.0K
Net Income	$-628.0K	$2M	$-2M	$-335.0K	$-392.0K	$-2M	$142.0K	$-28M	$-171.0K	$-2M	$618.0K	$580.0K	$-791.0K	$22M	$7M	$4M
EPS (Basic)	$-0.08	$0.30	$-0.31	$-0.05	$-0.05	$-0.31	$0.02	$-3.84	$-0.02	$-0.27	$0.09	$0.08	$-0.11	$3.17	$0.87	$0.54
EPS (Diluted)	$-0.08	$0.30	$-0.31	$-0.05	$-0.05	$-0.31	$0.02	$-3.84	$-0.02	$-0.26	$0.08	$0.08	$-0.11	$3.01	$0.83	$0.52
Shares (Basic)	7,416,000	-14,764,000	7,415,000	7,382,000	7,360,000	-14,524,000	7,324,000	7,257,000	7,236,000	-14,712,000	7,239,000	7,358,000	7,425,000	-14,032,000	7,125,000	7,017,000
Shares (Diluted)	7,416,000	-14,764,000	7,415,000	7,382,000	7,360,000	-14,598,000	7,398,000	7,257,000	7,236,000	-14,934,000	7,314,000	7,505,000	7,425,000	-14,741,000	7,524,000	7,388,000
EBITDA	$314.0K	·	$509.0K	$34.0K	$1M	·	$2M	$1M	$1M	·	$3M	$2M	$2M	·	$4M	$4M

Balance Sheet 26

Quarterly Balance Sheet data for HHS
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$5M	$6M	$7M	$5M	$9M	$10M	$6M	$11M	$11M	$18M	$13M	$13M	$13M	$10M	$7M	$11M
Receivables	$26M	$28M	$30M	$34M	$30M	$32M	$33M	$31M	$33M	$34M	$33M	$36M	$37M	$40M	$45M	$45M
Prepaid Expense	$3M	$2M	$2M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$3M	$3M	$3M	$2M	$2M	$3M
Other Current Assets	$2M	$2M	$2M	$951.0K	$1M	$1M	$1M	$1M	$1M	$928.0K	$878.0K	$1M	$1M	$2M	$11M	$11M
Current Assets	$46M	$46M	$49M	$50M	$54M	$54M	$54M	$55M	$58M	$65M	$62M	$64M	$62M	$66M	$81M	$84M
PP&E (Net)	$8M	$8M	$8M	$8M	$9M	$9M	$9M	$8M	$8M	$9M	$9M	$10M	$10M	$11M	$11M	$9M
PP&E (Gross)	·	$43M	·	·	·	$47M	·	·	·	$45M	·	·	·	$55M	·	·
Accum. Depreciation	·	$35M	$35M	$40M	$39M	$38M	$39M	$38M	$37M	$37M	$38M	$37M	$45M	$44M	$48M	$52M
Goodwill	$295.0K	$295.0K	$295.0K	$295.0K	$295.0K	$295.0K	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	·	·
Intangibles	$322.0K	$370.0K	$418.0K	$466.0K	$514.0K	$563.0K	$2M	$2M	$3M	$3M	$3M	$3M	$3M	$4M	·	·
Other Non-current Assets	$694.0K	$564.0K	$565.0K	$513.0K	$656.0K	$717.0K	$734.0K	$853.0K	$1M	$1M	$1M	$1M	$2M	$2M	$2M	$2M
Total Assets	$90M	$92M	$93M	$95M	$101M	$102M	$108M	$110M	$113M	$123M	$111M	$115M	$115M	$120M	$111M	$114M
Accounts Payable	$11M	$13M	$18M	$19M	$22M	$13M	$21M	$20M	$16M	$23M	$19M	$18M	$20M	$22M	$21M	$17M
Accrued Liabilities	$6M	$6M	·	·	·	$8M	·	·	·	·	·	·	·	·	·	·
Current Liabilities	$31M	$30M	$33M	$31M	$36M	$35M	$37M	$36M	$40M	$48M	$39M	$40M	$38M	$44M	$46M	$42M
Capital Leases	$18M	$18M	$18M	$18M	$19M	$20M	$21M	$22M	$23M	$24M	·	·	·	$17M	·	·
Other Non-current Liabilities	$1M	$1M	$1M	$1M	$1M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$3M	$3M	$3M	$3M
Total Liabilities	$70M	$71M	$73M	$73M	$79M	$80M	$87M	$89M	$93M	$103M	$90M	$94M	$94M	$101M	$114M	$122M
Total Debt	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$0	$10M
Common Stock	$12M	$12M	$12M	$12M	$12M	$12M	$12M	$12M	$12M	$12M	$12M	$12M	$12M	$12M	$12M	$12M
Retained Earnings	$813M	$814M	$812M	$814M	$814M	$815M	$817M	$817M	$845M	$845M	$847M	$846M	$846M	$846M	$826M	$819M
Treasury Stock	$899M	$900M	$900M	$902M	$913M	$916M	$917M	$938M	$946M	$951M	$954M	$980M	$989M	$1.01B	$1.01B	$1.07B
AOCI	$-15M	$-15M	$-13M	$-13M	$-13M	$-14M	$-16M	$-17M	$-44M	$-44M	$-45M	$-45M	$-46M	$-48M	$-57M	$-55M
Stockholders' Equity	$20M	$21M	$20M	$22M	$21M	$22M	$21M	$21M	$20M	$20M	$21M	$21M	$21M	$19M	$-13M	$-18M
Liabilities + Equity	$90M	$92M	$93M	$95M	$101M	$102M	$108M	$110M	$113M	$123M	$111M	$115M	$115M	$120M	$111M	$114M
Shares Outstanding	7,419,470	7,414,794	7,414,794	7,406,421	7,364,430	7,357,450	7,353,162	7,279,945	7,240,905	7,224,718	7,216,314	7,201,071	7,485,314	7,402,614	7,218,033	7,032,528

Cash Flow 13

Quarterly Cash Flow data for HHS
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
D&A	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$952.0K	$1M	$1M	$964.0K	$580.0K	$585.0K
Stock-based Comp	$218.0K	$-63.0K	$150.0K	$220.0K	$-49.0K	$277.0K	$368.0K	$734.0K	$552.0K	$215.0K	$161.0K	$502.0K	$540.0K	$579.0K	$926.0K	$562.0K
Deferred Tax	$-25.0K	$-852.0K	$-25.0K	$-15.0K	$-36.0K	$975.0K	$-35.0K	$-10M	$-161.0K	$-1M	$-127.0K	$-140.0K	$-186.0K	$-20M	$0	$0
Restructuring	$160.0K	$257.0K	$538.0K	$149.0K	$838.0K	$286.0K	$836.0K	$427.0K	$853.0K	$6M	$0	$0	$0	$0	$0	$0
Other Non-cash	$-1M	·	·	·	$-1M	·	·	·	$-7M	·	·	·	$1M	·	·	·
Operating Cash Flow	$-575.0K	$737.0K	$3M	$-5M	$-818.0K	$4M	$-3M	$2M	$-6M	$4M	$2M	$3M	$2M	$7M	$12M	$11M
CapEx	$347.0K	$1M	$1M	$223.0K	$105.0K	$627.0K	$2M	$682.0K	$526.0K	$1M	$224.0K	$690.0K	$566.0K	$57.0K	$2M	$2M
Investing Cash Flow	$-347.0K	$-1M	$-1M	$-225.0K	$-103.0K	$-626.0K	$-2M	$-682.0K	$-525.0K	$-832.0K	$-222.0K	$-690.0K	$-565.0K	$-6M	$-2M	$-2M
Stock Repurchased	·	·	·	·	·	·	$0	·	·	$0	$491.0K	·	·	$0	$0	·
Financing Cash Flow	$-50.0K	$-41.0K	$-155.0K	$778.0K	$-68.0K	$-94.0K	$-163.0K	$-13.0K	$-149.0K	$-86.0K	$-818.0K	$-2M	$-265.0K	$-9M	$-11M	$5M
Net Change in Cash	$-1M	$-923.0K	$2M	$-4M	$-952.0K	$3M	$-5M	$-490.0K	$-7M	$5M	$-76.0K	$246.0K	$3M	$-8M	$-4M	$11M
Taxes Paid	$300.0K	$283.0K	$310.0K	$990.0K	$196.0K	$258.0K	$306.0K	$721.0K	$167.0K	$6M	$1M	$102.0K	$-5M	·	$350.0K	$650.0K
Free Cash Flow	$-922.0K	·	·	·	$-923.0K	·	·	·	$-6M	·	·	·	$1M	·	·	·

Profitability 7

Quarterly Profitability data for HHS
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Operating Margin	-2.1%	·	1.3%	0.09%	-0.10%	·	4.0%	3.0%	0.83%	·	6.2%	3.5%	2.2%	·	7.0%	8.3%
Net Margin	-1.7%	·	-5.8%	-0.87%	-0.94%	·	0.30%	-61.8%	-0.38%	·	1.3%	1.2%	-1.7%	·	13.3%	9.2%
Pretax Margin	-2.7%	·	0.81%	-1.1%	-1.5%	·	2.1%	-81.8%	-0.53%	·	5.4%	1.7%	-2.8%	·	15.6%	10.6%
EBITDA Margin	0.84%	·	1.3%	0.09%	2.5%	·	4.0%	3.0%	3.1%	·	6.2%	3.5%	4.5%	·	7.0%	8.3%
ROA	-0.66%	·	-2.3%	-0.33%	-0.37%	·	0.13%	-24.8%	-0.15%	·	0.56%	0.51%	-0.70%	·	6.4%	3.9%
ROE	-3.0%	·	-11.2%	-1.6%	-1.9%	·	0.68%	-135.2%	-0.84%	·	16.0%	40.9%	-401.5%	·	-28.0%	-14.8%
ROIC	-2.4%	·	-18.4%	0.12%	-0.12%	·	1.3%	5.0%	1.3%	·	3.5%	5.8%	3.0%	·	-25.2%	-45.2%

Liquidity & Solvency 4

Quarterly Liquidity & Solvency data for HHS
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio	1.5	·	1.5	1.6	1.5	·	1.5	1.5	1.4	·	1.6	1.6	1.6	·	1.8	2.0
Quick Ratio	1.0	·	1.1	1.3	1.1	·	1.1	1.1	1.1	·	1.2	1.2	1.3	·	1.1	1.3
Debt / Equity	·	·	·	·	·	·	·	·	·	·	·	·	·	·	0.0	-0.6
LT Debt / Equity	·	·	·	·	·	·	·	·	·	·	·	·	·	·	0.0	-0.6

Efficiency 2

Quarterly Efficiency data for HHS
Metric	Trend	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover		0.4	·	0.4	0.4	0.4	·	0.4	0.4	0.4	·	0.4	0.4	0.4	·	0.5	0.4
Receivables Turnover		1.3	·	1.2	1.2	1.3	·	1.4	1.4	1.3	·	1.2	1.2	1.1	·	1.1	1.0

Per Share 5

Quarterly Per Share data for HHS
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Book Value / Share	$2.71	·	$2.68	$3.00	$2.91	·	$2.86	$2.83	$2.76	·	$2.84	$2.85	$2.80	·	$-1.77	$-2.52
Revenue / Share	$5.02	·	$5.33	$5.23	$5.65	·	$6.44	$6.11	$6.28	·	$6.44	$6.36	$6.35	·	$7.16	$6.57
Cash Flow / Share	$-0.08	·	·	·	$-0.11	·	·	·	$-0.79	·	·	·	$0.23	·	·	·
Cash / Share	$0.61	·	$0.88	$0.64	$1.22	·	$0.81	$1.51	$1.58	·	$1.84	$1.86	$1.75	·	$0.96	$1.50
EPS (TTM)	$-0.49	·	$-0.39	$-3.92	$-3.89	·	$-3.76	$-3.70	$0.03	·	$0.88	$1.32	$1.63	·	$2.26	$2.70

Valuation (TTM) 13

Quarterly Valuation (TTM) data for HHS
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$157M	·	$167M	$173M	$180M	·	$185M	$185M	$187M	·	$196M	$197M	$199M	·	$201M	$196M
Net Income TTM	$-4M	·	$-3M	$-28M	$-28M	·	$-27M	$-27M	$236.0K	·	$8M	$11M	$14M	·	$19M	$23M
Market Cap	$17M	·	$28M	$29M	$35M	·	$55M	$59M	$54M	·	$47M	$39M	$70M	·	$80M	$90M
Enterprise Value	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$74M	$89M
P/E	-4.6	·	-9.5	-1.0	-1.2	·	-2.0	-2.2	249.3	·	7.4	4.2	5.8	·	4.9	4.7
P/S	0.1	·	0.2	0.2	0.2	·	0.3	0.3	0.3	·	0.2	0.2	0.4	·	0.4	0.5
P/B	0.8	·	1.4	1.3	1.7	·	2.6	2.9	2.7	·	2.3	1.9	3.4	·	-6.3	-5.1
P / Tangible Book	0.9	·	1.4	1.4	1.7	·	3.2	3.6	3.5	·	3.1	2.6	4.6	·	·	·
P / Cash Flow	-29.3	·	·	·	-43.2	·	·	·	-9.5	·	·	·	41.3	·	·	·
P / FCF	-18.3	·	·	·	-38.3	·	·	·	-8.7	·	·	·	61.9	·	·	·
EV / EBITDA	·	·	·	·	·	·	·	·	·	·	·	·	·	·	19.5	22.2
EV / Revenue	·	·	·	·	·	·	·	·	·	·	·	·	·	·	0.4	0.5
Earnings Yield	-21.6%	·	-10.5%	-98.5%	-81.0%	·	-50.5%	-45.6%	0.40%	·	13.5%	24.1%	17.3%	·	20.3%	21.2%

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$160M	$185M	$191M	$206M	$195M
Operating Margin %	0.24%	1.1%	1.8%	7.3%	3.9%
Net Income	$-811.0K	$-30M	$-2M	$37M	$15M
Diluted EPS	$-0.11	$-4.15	$-0.21	$4.75	$1.76

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debt / Equity	—	—	—	0.0	-0.2
Current Ratio	1.5	1.5	1.4	1.5	1.8
Quick Ratio	1.1	1.2	1.1	1.1	1.2

Cash Flow

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	$-4M	$-7M	$8M	$23M	$-5M

Latest News Recent headlines mentioning this company

US To Revoke Passports Of People Who Owe 'Significant' Child Support ZeroHedge · 1 week, 5 days ago
The Most Favored Nation Policy: early insights into Europe’s response Yahoo Finance · 1 month, 3 weeks ago
Trump HHS Launches Probe Into 13 States Over Abortion Coverage Mandates ZeroHedge · 1 month, 3 weeks ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

HHS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

HHS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

Moving averages & overlays

Volume

Oscillators

Momentum & trend

10-Year Performance Revenue, net income, margins and EPS trends

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Financial Health Debt, liquidity, solvency — balance sheet strength

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Dividends Yield, payout ratio, dividend history, 5Y CAGR

HHS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Peer Comparison Key metrics vs sector peers

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals